BGM
BGM Group Ltd. Class A Ordinary Shares
About: BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Employees: 323
0
Funds
holding %
of 7,463 funds
–
Analysts
bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
100% more funds holding
Funds holding: 5 [Q1] → 10 (+5) [Q2]
30% more capital invested
Capital invested by funds: $1.08M [Q1] → $1.4M (+$322K) [Q2]
0.05% more ownership
Funds ownership: 0.12% [Q1] → 0.17% (+0.05%) [Q2]
Financial journalist opinion
Charts implemented using
Lightweight Charts™